HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
RPL32
ribosomal protein L32
Chromosome 3 · 3p25.2
NCBI Gene: 6161Ensembl: ENSG00000144713.14HGNC: HGNC:10336UniProt: P62910
190PubMed Papers
20Diseases
6Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedHub Gene
RESEARCH IMPACT
Trending
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
cytosolic large ribosomal subunitcytosolic ribosomecytoplasmic translationRNA bindinginfluenzaDuchenne muscular dystrophycystic fibrosisRaynaud disease
✦AI Summary

RPL32 is a structural component of the large ribosomal subunit that participates in cytoplasmic protein synthesis 12. Beyond its canonical ribosomal function, RPL32 exhibits stress-sensing capabilities through redox modification of cysteine residues 91 and 96, enabling p53 activation in response to ATM inhibition in cancer cells 3. In hepatocellular carcinoma, RPL32 is highly expressed and promotes tumor progression, with elevated levels correlating with unfavorable patient outcomes and enhanced HCC cell proliferation, migration, and invasion 4. RPL32 demonstrates stable mRNA expression across diverse biological contexts, making it a suitable reference gene for quantitative RT-PCR normalization in bronchoalveolar cells, post-myocardial infarction heart tissue, and certain immune cell populations 567. However, its suitability as a reference gene varies by cell type; it showed poor stability in colon cancer cells and NK cells under specific conditions 87. These findings suggest RPL32 functions both as a housekeeping component of translation and as a context-dependent stress sensor influencing cell survival pathways.

Sources cited
1
RPL32 is a component of the large ribosomal subunit responsible for protein synthesis
PMID: 23636399
2
RPL32 is a component of the large ribosomal subunit responsible for protein synthesis
PMID: 32669547
3
RPL32 undergoes redox modification on cysteines 91 and 96 upon ATM inhibition, promoting p53 stability and stress response
PMID: 39854937
4
RPL32 is highly expressed in hepatocellular carcinoma, correlates with poor prognosis, and promotes HCC cell proliferation, migration, and invasion
PMID: 37017565
5
RPL32 shows stable mRNA expression in bronchoalveolar cells and is suitable as a reference gene for qRT-PCR normalization
PMID: 18671841
6
RPL32 is one of the most stable reference genes in rodent and human heart failure myocardium across developmental stages
PMID: 20331858
7
RPL32 showed poor stability as a reference gene in activated and non-activated human NK cells
PMID: 25914089
8
RPL32 is not a suitable reference gene for qPCR in human colon cancer cells treated with cottonseed-derived compounds
PMID: 36364387
Disease Associationsⓘ20
influenzaOpen Targets
0.46Moderate
Duchenne muscular dystrophyOpen Targets
0.46Moderate
cystic fibrosisOpen Targets
0.39Weak
Raynaud diseaseOpen Targets
0.34Weak
aniridiaOpen Targets
0.10Suggestive
Becker muscular dystrophyOpen Targets
0.10Suggestive
ovarian neoplasmOpen Targets
0.10Suggestive
non-Hodgkins lymphomaOpen Targets
0.09Suggestive
genetic disorderOpen Targets
0.09Suggestive
Blackfan-Diamond anemiaOpen Targets
0.09Suggestive
hepatitis B virus infectionOpen Targets
0.08Suggestive
SplenomegalyOpen Targets
0.08Suggestive
lung cancerOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
hepatocellular carcinomaOpen Targets
0.08Suggestive
arthritisOpen Targets
0.07Suggestive
cystinosisOpen Targets
0.07Suggestive
diffuse large B-cell lymphomaOpen Targets
0.07Suggestive
epilepsyOpen Targets
0.07Suggestive
hemophilia BOpen Targets
0.07Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets6
ATALURENApproved
80S Ribosome modulator
Duchenne muscular dystrophy
CITATUZUMAB BOGATOXPhase I
Epithelial cell adhesion molecule binding agent
ELX-02Phase II
80S Ribosome modulator
cystic fibrosis
MT-3724Phase II
80S Ribosome inhibitor
diffuse large B-cell lymphoma
TELIMOMAB ARITOXPhase II
T-cell surface glycoprotein CD5 binding agent
hepatitis B virus infection
ZOLIMOMAB ARITOXPhase II
T-cell surface glycoprotein CD5 binding agent
arthritis
Related Genes
RPL9Shared pathway100%RPL18Shared pathway100%RPL18AShared pathway100%RPL4Protein interaction100%RPL8Protein interaction100%RPL12Protein interaction100%
Tissue Expression6 tissues
Ovary
100%
Bone Marrow
63%
Lung
44%
Heart
32%
Liver
31%
Brain
31%
Gene Interaction Network
Click a node to explore
RPL32RPL9RPL18RPL18ARPL4RPL8RPL12
PROTEIN STRUCTURE
Preparing viewer…
PDB8A3D · 1.67 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.24Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.00 [0.00–0.24]
RankingsWhere RPL32 stands among ~20K protein-coding genes
  • #2,257of 20,598
    Most Researched190 · top quartile
  • #874of 1,025
    FDA-Approved Drug Targets1
  • #722of 17,882
    Most Constrained (LOEUF)0.24 · top 5%
Genes detectedRPL32
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells.
PMID: 18671841
BMC Mol Biol · 2008
1.00
2
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition.
PMID: 39854937
Redox Biol · 2025
0.90
3
Ribosomal protein L32 enhances hepatocellular carcinoma progression.
PMID: 37017565
Cancer Med · 2023
0.80
4
Reference gene alternatives to Gapdh in rodent and human heart failure gene expression studies.
PMID: 20331858
BMC Mol Biol · 2010
0.70
5
Gene loss, genome rearrangement, and accelerated substitution rates in plastid genome of Hypericum ascyron (Hypericaceae).
PMID: 35321651
BMC Plant Biol · 2022
0.64